Theravance Biopharma Inc (TBPH)
Free Cash Flow
$51.82M
TTM · Period ending: · USD
TBPH Free Cash Flow
Latest reported$51.82Mperiod ending
Latest reported$51.82Mperiod ending
TBPH TTM Free Cash Flow (-$123.69M → $51.82M)
TTM free cash flow
High-resolution chart · PNG
TBPH free cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Free Cash Flow (USD) |
|---|---|
| 51,818,000 | |
| 268,739,000 | |
| 238,499,000 | |
| 243,479,000 | |
| 244,776,000 | |
| 32,285,000 | |
| -11,867,000 | |
| -12,306,000 | |
| -9,602,000 | |
| -18,439,000 | |
| -29,485,000 | |
| -152,275,000 | |
| -171,848,000 | |
| -173,403,000 | |
| -187,563,000 | |
| -106,120,000 | |
| -130,525,000 | |
| -165,951,000 | |
| -211,264,000 | |
| -234,555,000 | |
| -267,151,000 | |
| -272,596,000 | |
| -257,019,000 | |
| -256,505,000 | |
| -222,123,000 | |
| -215,015,000 | |
| -241,373,000 | |
| -229,396,000 | |
| -235,549,000 | |
| -249,574,000 | |
| -120,107,000 | |
| -110,886,000 | |
| -123,159,000 | |
| -105,791,000 | |
| -203,458,000 | |
| -187,514,000 | |
| -137,234,000 | |
| -124,744,000 | |
| -101,124,000 | |
| -106,963,000 | |
| -126,775,000 | |
| -141,326,000 | |
| -171,504,000 | |
| -180,456,000 | |
| -184,637,000 | |
| -189,014,000 | |
| -178,262,000 | |
| -171,212,000 | |
| -167,546,000 | |
| -140,881,000 | |
| -123,693,000 | |
| -110,407,000 | |
| -102,617,000 |